Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5HS3

Human thymidylate synthase complexed with dUMP and 3-amino-2-benzoyl-4-methylthieno[2,3-b]pyridin-6-ol

Summary for 5HS3
Entry DOI10.2210/pdb5hs3/pdb
DescriptorThymidylate synthase, 2'-DEOXYURIDINE 5'-MONOPHOSPHATE, 3-amino-2-benzoyl-4-methylthieno[2,3-b]pyridin-6-ol, ... (4 entities in total)
Functional Keywordsnhibitor, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (Human)
Total number of polymer chains6
Total formula weight201704.37
Authors
Chen, D.,Almqvist, H.,Axelsson, H.,Jafari, R.,Mateus, A.,Haraldsson, M.,Larsson, A.,Artursson, P.,Molina, D.M.,Lundback, T.,Nordlund, P. (deposition date: 2016-01-25, release date: 2016-02-24, Last modification date: 2023-11-08)
Primary citationAlmqvist, H.,Axelsson, H.,Jafari, R.,Chen, D.,Mateus, A.,Haraldsson, M.,Larsson, A.,Molina, D.M.,Artursson, P.,Lundback, T.,Nordlund, P.
CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil
Nat Commun, 7:11040-11040, 2016
Cited by
PubMed Abstract: Target engagement is a critical factor for therapeutic efficacy. Assessment of compound binding to native target proteins in live cells is therefore highly desirable in all stages of drug discovery. We report here the first compound library screen based on biophysical measurements of intracellular target binding, exemplified by human thymidylate synthase (TS). The screen selected accurately for all the tested known drugs acting on TS. We also identified TS inhibitors with novel chemistry and marketed drugs that were not previously known to target TS, including the DNA methyltransferase inhibitor decitabine. By following the cellular uptake and enzymatic conversion of known drugs we correlated the appearance of active metabolites over time with intracellular target engagement. These data distinguished a much slower activation of 5-fluorouracil when compared with nucleoside-based drugs. The approach establishes efficient means to associate drug uptake and activation with target binding during drug discovery.
PubMed: 27010513
DOI: 10.1038/ncomms11040
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.103 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon